Aimmune Therapeutics Inc (AIMT)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

8000 MARINA BOULEVARD BRISBANE, CA 94005-1884

Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers worldwide.

Data as of 2020-10-03
Market Cap2.248 Billion Shares Outstanding65.45 Million Avg 30-day Volume3.406 Million
P/E Ratio Dividend Yield EPS-4.49
Price/Sales3909.94 Price cash flow ratio Price free cash flow ratio-12.4
Book Value2.75 Price to Tangible Book12.53 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.079728
BETA1.74007 52-week High/Low37.0 / 10.09 Stddev0.26466
View SEC Filings from AIMT instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 9 1 800.0% 6 (0.39%) 0 (0.0%)
Funds Holding: 185 160 15.63% 61 (4.01%) 42 (2.73%) 45.24%
13F shares: 43.565 Million 48.792 Million -10.71% 19.409 Million 13.983 Million 38.8%
% Ownership 66.5614 74.5489 -10.71% 29.6544 21.3648 38.8%
New Positions: 85 25 240.0% 36 11 227.27%
Increased Positions 29 71 -59.15% 7 17 -58.82%
Closed Positions 59 22 168.18% 17 10 70.0%
Reduced Positions 50 34 47.06% 15 9 66.67%
Total Calls 1.418 Million 563.904 Thousand 151.53% 389.3 Thousand 176 Thousand 121.19%
Total Puts 1.087 Million 306.316 Thousand 254.89% 553.366 Thousand 121.8 Thousand 354.32%
PUT/CALL Ratio 0.77 0.54 42.59% 1.42 0.69 105.8%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

 
Aimmune Therapeutics Inc Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding AIMT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AIMT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BEHAR GREGORY

  • Director
 0 2020-10-13 2

SOCIETE DES PRODUITS NESTLE S.A.

  • 10% Owner
 80,097,147 2020-10-13 2

MCDADE MARK

  • Director
 0 2020-10-10 2

SELTZER STACEY DENENBERG

  • Director
 0 2020-10-10 2

ENRIGHT PATRICK G

  • Director
 0 2020-10-10 4

FALBERG KATHRYN E

  • Director
 0 2020-10-10 2

IWICKI MARK T

  • Director
 0 2020-10-10 2

SHEEHY DOUGLAS T. SEE REMARKS

  • Officer
 0 2020-10-10 6

ADELMAN DANIEL C MD CHIEF MEDICAL OFFICER

  • Officer
 0 2020-10-10 6

BJERKHOLT ERIC CHIEF FINANCIAL OFFICER

  • Officer
 0 2020-10-10 8

DALLAS JAYSON DONALD ALEXANDER PRESIDENT AND CEO

  • Officer
  • Director
 0 2020-10-10 7

HAUMANN BRETT K

  • Director
 0 2020-10-10 2

OXTOBY ANDREW CHIEF COMMERCIAL OFFICER

  • Officer
 0 2020-10-10 6

SOCIETE DES PRODUITS NESTLE S.A.

NESTLE SA

  • 10% Owner
 26,505,494 2020-02-07 2

ROZENMAN MARY M. SEE REMARKS

  • Officer
 13,878 2019-12-31 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

SOCIETE DES PRODUITS NESTLE S.A.

NESTLE SA

NIMCO US, INC.

NESTLE US HOLDCO, INC.

  • 10% Owner
 11,727,113 2018-12-31 0

BARROWCLIFFE SUSAN E. GENERAL MANAGER, EUROPE

  • Officer
 9,375 2018-11-19 0

DILLY STEPHEN GEORGE PRESIDENT AND CEO

  • Officer
  • Director
 447,008 2018-06-11 0

KNAPP JEFFREY H CHIEF OPERATING OFFICER

  • Officer
 12,151 2018-03-04 0

NESTLE HEALTH SCIENCE US HOLDINGS, INC.

NESTLE SA

NIMCO US, INC.

  • 10% Owner
 11,727,113 2018-02-26 0

TAMMENOMS BAKKER JULIET

  • 10% Owner
 6,029,785 2018-02-22 0

DESOUZA WARREN L. CHIEF FINANCIAL OFFICER

  • Officer
 20,681 2017-04-03 0

LONGITUDE CAPITAL PARTNERS II, LLC

TAMMENOMS BAKKER JULIET

LONGITUDE VENTURE PARTNERS II, L.P.

  • 10% Owner
 6,020,410 2016-11-29 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL FUND III, L.P.

TANANBAUM JAMES B.

  • 10% Owner
 4,902,920 2016-08-18 0

LONGITUDE CAPITAL PARTNERS II, LLC

LONGITUDE VENTURE PARTNERS II, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

  • 10% Owner
 7,513,134 2016-03-29 0

ELFONT ROBERT MYLES CHIEF MEDICAL OFFICER

  • Officer
 299,002 2016-02-26 0

FORESITE CAPITAL MANAGEMENT II, LLC

FORESITE CAPITAL FUND II, L.P.

TANANBAUM JAMES B.

  • 10% Owner
 0 2015-08-05 0

RAFF HOWARD V. CHIEF OPERATING OFFICER

  • Officer
 428,575 2015-08-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments